1518.8000 30.70 (2.06%)
NSE Sep 24, 2025 15:31 PM
Volume: 235.8K
High volume today

1518.80
2.06%
Prabhudas Lilladhar
JLHL's Q4 consolidated EBITDA grew by 26% YoY (4% QoQ) to Rs783mn, largely in line with our estimates, aided by higher ARPOB. Its operational efficiency has been strong in the competitive markets of MMR. The company reported revenue/EBITDA CAGR of 20%/25% over FY22-25. Given its expansion plans, scale-up in occupancy and improving margins, growth momentum is expected to sustain over the medium term. We believe strategic greenfield expansions in densely populated micro-markets of western regions...
Jupiter Life Line Hospitals Ltd. is trading above all available SMAs
More from Jupiter Life Line Hospitals Ltd.
Recommended